Nonalcoholic steatohepatitis and hepatocellular carcinoma in galectin-3 knockout mice

被引:33
|
作者
Nakanishi, Yuko [1 ]
Tsuneyama, Koichi [1 ,5 ]
Nomoto, Kazuhiro [1 ]
Fujimoto, Makoto [2 ]
Salunga, Thucydides L. [1 ,5 ,6 ]
Nakajima, Takahiko [3 ]
Miwa, Shigeharu [3 ]
Murai, Yoshihiro [1 ]
Hayashi, Shinichi [1 ]
Kato, Ichiro [4 ]
Hiraga, Koichi [4 ]
Hsu, Daniel K. [7 ]
Liu, Fu-Tong [7 ]
Takano, Yasuo [1 ]
机构
[1] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Diagnost Pathol, Toyama 9300194, Japan
[2] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Japanese Oriental Med, Toyama 9300194, Japan
[3] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Gastroenterol & Hematol, Toyama 9300194, Japan
[4] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Biochem, Toyama 9300194, Japan
[5] Toyama Univ, 21st Century COE Program, Toyama 9300194, Japan
[6] Univ Philippines, Inst Biol, Quezon City 1101, Philippines
[7] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA
基金
日本学术振兴会;
关键词
computed tomography; galectin-3; hepatocellular carcinoma; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis;
D O I
10.1111/j.1872-034X.2008.00395.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim: Nonalcoholic fatty liver disease (NAFLD) represents a growing health concern due to its rapidly increasing prevalence worldwide. Nonalcoholic steatohepatitis (NASH) is a progressing form of NAFLD, and recently many studies have reported that it could eventually develop into hepatocellular carcinoma (HCC). We previously reported that 6-month-old male galectin-3 knockout (gal3(-/-)) mice developed clinicopathological features similar to those of NAFLD in humans. Our aim was to investigate the changes in liver histology in gal3(-/-) mice by long-term observation. Methods: We initially investigated three 15-month-old gal3(-/-) mice, of which two developed multiple liver nodules with dysplastic changes. Then, we histopathologically examined the liver specimens of the 15-, 20- and 25-month-old gal3(-/-) mice and attempted to evaluate the liver morphology by contrast enhanced computed tomography (CT) before sacrifice. Results: At the age of 15 months or later, gal3(-/-) mice developed liver nodules with varying degrees of architectural and nuclear atypia based on mild to moderate delicate zone 3 fibrosis. In addition, we successfully confirmed the presence of some of the liver nodules by CT. We report herein that gal3(-/-) mice develop dysplastic liver nodules and HCC. Conclusions: We believe that it would be interesting to use this murine model to investigate liver carcinogenesis based on a natural history of NAFLD. Furthermore, CT scanning might be a useful tool for longitudinal evaluation of morphological changes in vivo.
引用
收藏
页码:1241 / 1251
页数:11
相关论文
共 50 条
  • [21] Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma
    Jiang, Shan-Shan
    Weng, De-Sheng
    Wang, Qi-Jing
    Pan, Ke
    Zhang, Yao-Jun
    Li, Yong-Qiang
    Li, Jian-Jun
    Zhao, Jing-Jing
    He, Jia
    Lv, Lin
    Pan, Qiu-Zhong
    Xia, Jian-Chuan
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [22] Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma
    Hsu, DK
    Dowling, CA
    Jeng, KCG
    Chen, JT
    Yang, RY
    Liu, FT
    INTERNATIONAL JOURNAL OF CANCER, 1999, 81 (04) : 519 - 526
  • [23] Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma
    Shan-Shan Jiang
    De-Sheng Weng
    Qi-Jing Wang
    Ke Pan
    Yao-Jun Zhang
    Yong-Qiang Li
    Jian-Jun Li
    Jing-Jing Zhao
    Jia He
    Lin Lv
    Qiu-Zhong Pan
    Jian-Chuan Xia
    Journal of Translational Medicine, 12
  • [24] Blood circulating Galectin-3 is a prognostic biomarker in hepatocellular carcinoma
    Chamseddine, S.
    Kaseb, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S600 - S600
  • [25] Galectin-3 (Gal-3) Expression in Relation to Fibrosis in Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
    Goodman, Zachary D.
    Mulder, Christopher
    Bolduc, Caroline A.
    Raines, Matthew F.
    Cebe, Katherine M.
    Alaparthi, Lakshmi
    Monge, Fanny
    Traber, Peter G.
    Harrison, Stephen A.
    GASTROENTEROLOGY, 2014, 146 (05) : S951 - S951
  • [26] Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma
    Massoud, Omar
    Charlton, Michael
    CLINICS IN LIVER DISEASE, 2018, 22 (01) : 201 - +
  • [27] Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma: Brazilian Survey
    Ferreira Alves, Venancio Avancini
    Carneiro D'Albuquerque, Luiz Augusto
    CLINICS, 2016, 71 (08) : 423 - 424
  • [28] Advances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinoma
    Fauzia Z Khan
    Ryan B Perumpail
    Robert J Wong
    Aijaz Ahmed
    World Journal of Hepatology, 2015, 7 (18) : 2155 - 2161
  • [29] Advances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinoma
    Khan, Fauzia Z.
    Perumpail, Ryan B.
    Wong, Robert J.
    Ahmed, Aijaz
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (18) : 2155 - 2161
  • [30] Nonalcoholic steatohepatitis and hepatocellular carcinoma:: Natural history?
    Cotrim, HP
    Paraná, R
    Braga, E
    Lyra, L
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (10): : 3018 - 3019